Immunochemical analysis of poly(ADP-ribosyl)ation in HaCaT keratinocytes induced by the mono-alkylating agent 2-chloroethyl ethyl sulfide (CEES) : impact of experimental conditions

dc.contributor.authorDebiak, Malgorzata
dc.contributor.authorLex, Kirsten
dc.contributor.authorPonath, Viviane
dc.contributor.authorBurckhardt-Boer, Waltraud
dc.contributor.authorThiermann, Horst
dc.contributor.authorSteinritz, Dirk
dc.contributor.authorSchmidt, Annette
dc.contributor.authorMangerich, Aswin
dc.contributor.authorBürkle, Alexander
dc.date.accessioned2015-09-25T09:55:43Z
dc.date.available2015-09-25T09:55:43Z
dc.date.issued2016-02-26
dc.description.abstractSulfur mustard (SM) is a bifunctional alkylating agent with a long history of use as a chemical weapon. Although its last military use is dated for the eighties of the last century, a potential use in terroristic attacks against civilians remains a significant threat. Thus, improving medical therapy of mustard exposed individuals is still of particular interest. PARP inhibitors were recently brought into the focus as a potential countermeasure for mustard-induced pathologies, supported by the availability of efficient compounds successfully tested in cancer therapy.
PARP activation after SM treatment was reported in several cell types and tissues under various conditions; however, a detailed characterization of this phenomenon is still missing. This study provides the basis for such studies by developing and optimizing experimental conditions to investigate poly(ADP-ribosyl) ation (PARylation) in HaCaT keratinocytes upon treatment with the monofunctional alkylating agent 2-chloroethyl ethyl sulfide ("half mustard", CEES). By using an immunofluorescence-based approach, we show that optimization of experimental conditions with regards to the type of solvent, dilution factors and treatment procedure is essential to obtain a homogenous PAR staining in HaCaT cell cultures. Furthermore, we demonstrate that different CEES treatment protocols significantly influence the cytotoxicity profiles of treated cells. Using an optimized treatment protocol, our data reveals that CEES induces a dose- and time-dependent dynamic PARylation response in HaCaT cells that could be completely blocked by treating cells with the clinically relevant pharmacological PARP inhibitor ABT888 (also known as veliparib). Finally, siRNA experiments show that CEES-induced PAR formation is predominantly due to the activation of PARP1. In conclusion, this study provides a detailed analysis of the CEES-induced PARylation response in HaCaT keratinocytes, which forms an experimental basis to study the molecular mechanism of PARP1 activation and its functional consequences after mustard treatment in general. Such a study is presented in an accompanying article (Mangerich/Debiak/Birtel et al., this issue).
eng
dc.description.versionpublished
dc.identifier.doi10.1016/j.toxlet.2015.09.009eng
dc.identifier.pmid26383632eng
dc.identifier.ppn474052451
dc.identifier.urihttp://kops.uni-konstanz.de/handle/123456789/31834
dc.language.isoengeng
dc.rightsterms-of-use
dc.rights.urihttps://rightsstatements.org/page/InC/1.0/
dc.subjectCEES; HaCaT keratinocytes; Poly(ADP-ribose); poly(ADP-ribose) polymerases; solvent; sulfur mustardeng
dc.subject.ddc570eng
dc.titleImmunochemical analysis of poly(ADP-ribosyl)ation in HaCaT keratinocytes induced by the mono-alkylating agent 2-chloroethyl ethyl sulfide (CEES) : impact of experimental conditionseng
dc.typeJOURNAL_ARTICLEeng
dspace.entity.typePublication
kops.citation.bibtex
@article{Debiak2016-02-26Immun-31834,
  year={2016},
  doi={10.1016/j.toxlet.2015.09.009},
  title={Immunochemical analysis of poly(ADP-ribosyl)ation in HaCaT keratinocytes induced by the mono-alkylating agent 2-chloroethyl ethyl sulfide (CEES) : impact of experimental conditions},
  volume={244},
  issn={0378-4274},
  journal={Toxicology Letters},
  pages={72--80},
  author={Debiak, Malgorzata and Lex, Kirsten and Ponath, Viviane and Burckhardt-Boer, Waltraud and Thiermann, Horst and Steinritz, Dirk and Schmidt, Annette and Mangerich, Aswin and Bürkle, Alexander}
}
kops.citation.iso690DEBIAK, Malgorzata, Kirsten LEX, Viviane PONATH, Waltraud BURCKHARDT-BOER, Horst THIERMANN, Dirk STEINRITZ, Annette SCHMIDT, Aswin MANGERICH, Alexander BÜRKLE, 2016. Immunochemical analysis of poly(ADP-ribosyl)ation in HaCaT keratinocytes induced by the mono-alkylating agent 2-chloroethyl ethyl sulfide (CEES) : impact of experimental conditions. In: Toxicology Letters. 2016, 244, pp. 72-80. ISSN 0378-4274. eISSN 1879-3169. Available under: doi: 10.1016/j.toxlet.2015.09.009deu
kops.citation.iso690DEBIAK, Malgorzata, Kirsten LEX, Viviane PONATH, Waltraud BURCKHARDT-BOER, Horst THIERMANN, Dirk STEINRITZ, Annette SCHMIDT, Aswin MANGERICH, Alexander BÜRKLE, 2016. Immunochemical analysis of poly(ADP-ribosyl)ation in HaCaT keratinocytes induced by the mono-alkylating agent 2-chloroethyl ethyl sulfide (CEES) : impact of experimental conditions. In: Toxicology Letters. 2016, 244, pp. 72-80. ISSN 0378-4274. eISSN 1879-3169. Available under: doi: 10.1016/j.toxlet.2015.09.009eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/31834">
    <dc:creator>Bürkle, Alexander</dc:creator>
    <dc:language>eng</dc:language>
    <dcterms:title>Immunochemical analysis of poly(ADP-ribosyl)ation in HaCaT keratinocytes induced by the mono-alkylating agent 2-chloroethyl ethyl sulfide (CEES) : impact of experimental conditions</dcterms:title>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:creator>Steinritz, Dirk</dc:creator>
    <dcterms:issued>2016-02-26</dcterms:issued>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-09-25T09:55:43Z</dcterms:available>
    <dc:contributor>Burckhardt-Boer, Waltraud</dc:contributor>
    <dc:creator>Thiermann, Horst</dc:creator>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Schmidt, Annette</dc:contributor>
    <dc:creator>Debiak, Malgorzata</dc:creator>
    <dc:contributor>Ponath, Viviane</dc:contributor>
    <dc:creator>Ponath, Viviane</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/31834/1/Debiak_0-300780.pdf"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Thiermann, Horst</dc:contributor>
    <dc:contributor>Lex, Kirsten</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/31834/1/Debiak_0-300780.pdf"/>
    <dc:creator>Mangerich, Aswin</dc:creator>
    <dcterms:abstract xml:lang="eng">Sulfur mustard (SM) is a bifunctional alkylating agent with a long history of use as a chemical weapon. Although its last military use is dated for the eighties of the last century, a potential use in terroristic attacks against civilians remains a significant threat. Thus, improving medical therapy of mustard exposed individuals is still of particular interest. PARP inhibitors were recently brought into the focus as a potential countermeasure for mustard-induced pathologies, supported by the availability of efficient compounds successfully tested in cancer therapy.&lt;br /&gt;PARP activation after SM treatment was reported in several cell types and tissues under various conditions; however, a detailed characterization of this phenomenon is still missing. This study provides the basis for such studies by developing and optimizing experimental conditions to investigate poly(ADP-ribosyl) ation (PARylation) in HaCaT keratinocytes upon treatment with the monofunctional alkylating agent 2-chloroethyl ethyl sulfide ("half mustard", CEES). By using an immunofluorescence-based approach, we show that optimization of experimental conditions with regards to the type of solvent, dilution factors and treatment procedure is essential to obtain a homogenous PAR staining in HaCaT cell cultures. Furthermore, we demonstrate that different CEES treatment protocols significantly influence the cytotoxicity profiles of treated cells. Using an optimized treatment protocol, our data reveals that CEES induces a dose- and time-dependent dynamic PARylation response in HaCaT cells that could be completely blocked by treating cells with the clinically relevant pharmacological PARP inhibitor ABT888 (also known as veliparib). Finally, siRNA experiments show that CEES-induced PAR formation is predominantly due to the activation of PARP1. In conclusion, this study provides a detailed analysis of the CEES-induced PARylation response in HaCaT keratinocytes, which forms an experimental basis to study the molecular mechanism of PARP1 activation and its functional consequences after mustard treatment in general. Such a study is presented in an accompanying article (Mangerich/Debiak/Birtel et al., this issue).</dcterms:abstract>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-09-25T09:55:43Z</dc:date>
    <dc:creator>Schmidt, Annette</dc:creator>
    <dc:contributor>Debiak, Malgorzata</dc:contributor>
    <dc:contributor>Steinritz, Dirk</dc:contributor>
    <dc:creator>Lex, Kirsten</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/31834"/>
    <dc:contributor>Mangerich, Aswin</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Bürkle, Alexander</dc:contributor>
    <dc:creator>Burckhardt-Boer, Waltraud</dc:creator>
  </rdf:Description>
</rdf:RDF>
kops.description.openAccessopenaccessgreen
kops.flag.knbibliographytrue
kops.identifier.nbnurn:nbn:de:bsz:352-0-300780
kops.sourcefieldToxicology Letters. 2016, <b>244</b>, pp. 72-80. ISSN 0378-4274. eISSN 1879-3169. Available under: doi: 10.1016/j.toxlet.2015.09.009deu
kops.sourcefield.plainToxicology Letters. 2016, 244, pp. 72-80. ISSN 0378-4274. eISSN 1879-3169. Available under: doi: 10.1016/j.toxlet.2015.09.009deu
kops.sourcefield.plainToxicology Letters. 2016, 244, pp. 72-80. ISSN 0378-4274. eISSN 1879-3169. Available under: doi: 10.1016/j.toxlet.2015.09.009eng
relation.isAuthorOfPublication0a47d534-56a0-412a-9825-24754aa0f251
relation.isAuthorOfPublication479c2f14-fc17-471e-92e1-18215fd11b3b
relation.isAuthorOfPublication3a2d6259-be3e-4a80-9ccf-68c92532a633
relation.isAuthorOfPublication5cbfcfa4-9719-4d4b-9f4c-9d148690039a
relation.isAuthorOfPublication92134975-55fc-4ed4-b6b4-ac475ab0944e
relation.isAuthorOfPublication99f10fd7-72b9-483a-9c91-e43d378c52d0
relation.isAuthorOfPublication.latestForDiscovery0a47d534-56a0-412a-9825-24754aa0f251
source.bibliographicInfo.fromPage72
source.bibliographicInfo.toPage80
source.bibliographicInfo.volume244
source.identifier.eissn1879-3169eng
source.identifier.issn0378-4274eng
source.periodicalTitleToxicology Letterseng
temp.internal.duplicates<p>Keine Dubletten gefunden. Letzte Überprüfung: 23.09.2015 14:23:09</p>deu

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
Debiak_0-300780.pdf
Größe:
2.22 MB
Format:
Adobe Portable Document Format
Beschreibung:
Debiak_0-300780.pdf
Debiak_0-300780.pdfGröße: 2.22 MBDownloads: 681